Mostrar el registro sencillo del ítem

dc.contributor.authorBorda, Miguel Germán
dc.contributor.authorAarsland, Dag
dc.contributor.authorCano Gutierrez, Carlos Alberto
dc.contributor.authorPerez Zepeda, Mario Ulises
dc.date.accessioned2022-01-25T16:24:35Z
dc.date.accessioned2023-05-10T17:07:21Z
dc.date.available2022-01-25T16:24:35Z
dc.date.available2023-05-10T17:07:21Z
dc.date.created2022-01-22
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0022510X22000156?via%3Dihubspa
dc.identifier.issn0022-510Xspa
dc.identifier.urihttps://hdl.handle.net/20.500.12032/90119
dc.description.abstractThe growing incidence of dementia has led to an increased need for specialized care and higher health and social costs. Functional decline is the main cause of dementia complications. Per definition, dementia diagnosis and severity stratification require a certain degree of functional impairment [1]. Therefore, it is important to determine strategies to prevent functional deterioration in both, general population and especially people with dementia. The number of older adults with some degree of disability will triple by 2050 due to the increase in the aging population and the prevalence of age-related diseases that lead to functional impairment [2]. Therefore, functional impairment and disability in old people are increasingly becoming a major public health concern. Furthermore, functional impairment severely impairs quality of life and consumes a large proportion of the public health resources, creating an important burden for health care systems. It is well known that functional loss and disability in dementia are the main consequences of cognitive decline. Therefore, most of the efforts in dementia management have been directed to stop or reverse cognitive decline. However, functional loss and disability are also the consequence of other conditions that are common in old age and comorbid with dementia, such as frailty, sarcopenia, malnutrition, falls, pulmonary or cardiovascular diseases, polypharmacy, depression, and neuropsychiatric symptoms (NPS) [3].spa
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectDemenciaspa
dc.subjectAlzheimerspa
dc.subjectCuerpos de Lewyspa
dc.subjectDiscapacidadspa
dc.subjectEnvejecimientospa
dc.subjectCapacidad funcionalspa
dc.titleActions to be taken for improving functional prognosis in dementiaspa


Ficheros en el ítem

FicherosTamañoFormatoVer
Actions to be taken for improving.pdf506.7Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by-nc/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc/4.0/

© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP